GF
AMED

Gabelli Funds’s Amedisys AMED Stock Holding History

Gabelli Funds’s Portfolio AMED Stock Details AMED Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		– Sell
-201,903
Closed -$19.9M – 1246
2025
Q2 		$19.9M Buy
201,903
+13,600
+7% +$1.29M 0.14% 190
2025
Q1 		$17.4M Buy
188,303
+6,329
+3% +$583K 0.13% 203
2024
Q4 		$16.5M Sell
181,974
-9,937
-5% -$913K 0.12% 221
2024
Q3 		$18.5M Sell
191,911
-24,426
-11% -$2.38M 0.13% 213
2024
Q2 		$19.9M Sell
216,337
-7,065
-3% -$656K 0.15% 186
2024
Q1 		$20.6M Sell
223,402
-723
-0.3% -$67.8K 0.15% 190
2023
Q4 		$21.3M Buy
224,125
+44,340
+25% +$4.14M 0.16% 174
2023
Q3 		$16.8M Buy
179,785
+142,085
+377% +$13.1M 0.14% 209
2023
Q2 		$3.45M Buy
+37,700
New +$3.09M 0.03% 542

Other funds holding AMED

Osaic Holdings
Osaic Holdings Scottsdale, Arizona $68.3B AUM 20.5% 1-Year Est. Return
IA
IFP Advisors Tampa, Florida $4.82B AUM 20.19% 1-Year Est. Return
MCI
MRP Capital Investments Alpharetta, Georgia $115M AUM 48.08% 1-Year Est. Return
HNB
Huntington National Bank Columbus, Ohio $18.1B AUM 24.69% 1-Year Est. Return

Gabelli Funds's AMED Position: Q3 2025 in Review

Gabelli Funds sold out of Amedisys (AMED) in Q3 2025, closing a stake of 201,903 shares — an estimated $19.9M sold.

Gabelli Funds first reported a position in AMED in Q2 2023 and held it in 9 quarters. The position peaked at $21.3M in Q4 2023. 4 funds tracked by Wall St. Rank hold AMED as of Q3 2025.

  • Gabelli Funds reported no remaining Amedisys position as of Q3 2025 after selling out during the quarter.
  • Gabelli Funds sold 201,903 Amedisys shares in Q3 2025, an estimated $19.9M.
  • Gabelli Funds first reported a position in Amedisys in Q2 2023 and held it in 9 quarters.
  • Gabelli Funds's Amedisys position peaked at $21.3M in Q4 2023.
  • 4 funds tracked by Wall St. Rank held Amedisys as of Q3 2025.

Based on Gabelli Funds's 13F filing for Q3 2025, filed 12 Nov 2025.